Novomix 30 flexpen
NovoMix 30 FlexPen is a prefilled insulin pen containing a mixture of 30% rapid-acting insulin and 70% intermediate-acting insulin. Widely used in Nigeria, it helps control blood sugar levels in people with diabetes, providing both mealtime and basal insulin coverage to maintain stable glucose levels when used as prescribed by a healthcare professional.
Novomix® 30 FlexPen – Novo Nordisk
Novomix® 30 FlexPen is a pre-filled insulin pen containing a premixed insulin solution of 30% rapid-acting insulin and 70% intermediate-acting insulin. It is designed to help people with diabetes achieve better blood glucose control by covering both mealtime spikes and basal insulin needs.
Key Benefits:
- Premixed insulin for both mealtime and basal coverage
- Flexible dosing with easy-to-use pen device
- Rapid-acting component helps control post-meal blood sugar
- Intermediate-acting component provides lasting glucose control
- Convenient for self-administration
Typical Uses:
- Type 1 and type 2 diabetes requiring insulin therapy
- Patients needing both rapid- and intermediate-acting insulin coverage
- Managing blood sugar fluctuations throughout the day
Directions for Use:
Inject subcutaneously as prescribed by your healthcare professional, usually before meals. Rotate injection sites to prevent skin problems. Do not share pens with others.
Storage:
Unopened pens: store in a refrigerator (2–8°C).
Opened pens: can be kept at room temperature (below 30°C) and used within 4 weeks. Keep out of reach of children.
Important Information:
- Use only under medical supervision
- Monitor blood glucose regularly
- Be aware of signs of hypoglycemia (low blood sugar)
- Do not use if the solution appears cloudy or discolored (unless it is the expected appearance)







